EPBRIV 0.88MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹9754.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Epbriv 0.88MG Injection, 1 vial, salt eribulin mesylate 0.88mg. NPPA has revised its MRP from Rs 24,739 to Rs 9,754 (61% lower) with effect from 09-11-2026; trade rate Rs 7,431.62. Group: microtubule inhibitor chemotherapy. No other manufacturer of this salt and strength is listed here yet. Handling/counselling: short IV injection in day-care; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.